TrialClinical pharmacokinetics2024

Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers.

Ahmed Nader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.